Gilead Sciences Inc. (GILD)
NASDAQ: GILD
· Real-Time Price · USD
118.74
-0.28 (-0.24%)
At close: Aug 15, 2025, 2:46 PM
Gilead Sciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 1.96B | 1.31B | 1.78B | 1.25B | 1.61B | -4.17B | 1.42B | 2.17B | 1.04B | 985M | 1.63B | 1.79B | 1.14B | 12M | 376M | 2.59B | 1.52B | 1.72B |
Depreciation & Amortization | 691M | 696M | 693M | 690M | 694M | 690M | 688M | 684M | 681M | 640M | 528M | 525M | 525M | 525M | 535M | 523M | 519M | 473M |
Stock-Based Compensation | 225M | 209M | 222M | 216M | 210M | 187M | 201M | 202M | 198M | 165M | 174M | 168M | 165M | 130M | 159M | 171M | 166M | 139M |
Other Working Capital | -1.39B | -784M | 695M | 206M | -1.36B | -420M | -413M | -826M | 646M | -678M | 410M | 284M | -144M | -1.82B | 1.61B | -81M | -188M | -1.06B |
Other Non-Cash Items | 143M | 769M | 173M | 2.08B | 519M | 6.69B | 776M | 314M | 310M | 799M | 453M | 771M | 871M | 2.99B | 680M | 186M | 645M | 614M |
Deferred Income Tax | -178M | -199M | -379M | -576M | -166M | -723M | -370M | -68M | -221M | -303M | -338M | -270M | -293M | -651M | -359M | 240M | -68M | 71M |
Change in Working Capital | -2.01B | -1.03B | 483M | 642M | -1.55B | -459M | -543M | -1.55B | 331M | -542M | 117M | -117M | -601M | -1.16B | 1.81B | -453M | -463M | -409M |
Operating Cash Flow | 827M | 1.76B | 2.98B | 4.31B | 1.32B | 2.22B | 2.17B | 1.75B | 2.34B | 1.74B | 2.57B | 2.86B | 1.8B | 1.84B | 3.21B | 3.25B | 2.32B | 2.61B |
Capital Expenditures | -107M | -104M | -147M | -141M | -130M | -105M | -215M | -122M | -139M | -109M | -181M | -157M | -143M | -247M | -156M | -139M | -119M | -165M |
Cash Acquisitions | -21M | -273M | -75M | -570M | -152M | -4.04B | -279M | -79M | -243M | -551M | -218M | -448M | -324M | -807M | -1M | -83M | -202M | -1.25B |
Purchase of Investments | -2.31B | -16M | -39M | -9M | -34M | -654M | -680M | -395M | -645M | -652M | -378M | -430M | -493M | -641M | -674M | -844M | -1.17B | -1.21B |
Sales Maturities Of Investments | 310M | n/a | n/a | n/a | n/a | 2.59B | 447M | 361M | 545M | 491M | 400M | 324M | 653M | 625M | 596M | 813M | 822M | 679M |
Other Investing Acitivies | 10M | -22M | 36M | 10M | 9M | 3M | n/a | 6M | -1M | -5M | 2M | -2M | -1M | n/a | -43M | 19M | 91M | -91M |
Investing Cash Flow | -2.12B | -415M | -225M | -710M | -307M | -2.21B | -727M | -229M | -483M | -826M | -375M | -713M | -308M | -1.07B | -278M | -234M | -577M | -2.04B |
Debt Repayment | -9M | -1.76B | 3.46B | -112M | -1.85B | n/a | 1M | -271M | n/a | n/a | n/a | -1B | n/a | -500M | -1B | -2.5B | n/a | -1.25B |
Common Stock Repurchased | -527M | -730M | -350M | -300M | -100M | -400M | -150M | -300M | -150M | -400M | -792M | -180M | -72M | -352M | -49M | -145M | -43M | -309M |
Dividend Paid | -994M | -1.01B | -973M | -983M | -972M | -990M | -943M | -953M | -944M | -969M | -915M | -929M | -920M | -945M | -894M | -900M | -894M | -917M |
Other Financial Acitivies | -64M | -176M | -47M | -82M | -35M | -117M | -33M | -78M | -33M | -134M | -23M | -45M | -14M | -91M | -11M | -39M | -6M | -89M |
Financial Cash Flow | -1.57B | -3.43B | 2.26B | -1.38B | -2.95B | -1.36B | -1.1B | -1.52B | -1.1B | -1.41B | -1.55B | -2.12B | -1B | -1.79B | -1.94B | -3.53B | -931M | -2.48B |
Net Cash Flow | -2.78B | -2.06B | 4.95B | 2.27B | -1.95B | -1.37B | 380M | 1M | 768M | -476M | 713M | -40M | 443M | -1.04B | 976M | -531M | 828M | -1.93B |
Free Cash Flow | 720M | 1.65B | 2.83B | 4.17B | 1.2B | 2.11B | 1.95B | 1.63B | 2.2B | 1.64B | 2.39B | 2.71B | 1.66B | 1.59B | 3.05B | 3.11B | 2.2B | 2.44B |